NCT07024719 4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
| NCT ID | NCT07024719 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Corneal Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 5 participants |
| Start Date | 2025-07-24 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5 participants in total. It began in 2025-07-24 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study team will conduct the first in-human pilot studies using 4D MIOCT for imaging in the operating room. Building on the earlier integration and wet-lab validations, the researchers will assess the system's ease of use, safety, and visualization of intended structures during various anterior and posterior segment ophthalmic procedures.
Eligibility Criteria
Inclusion Criteria: * Adult participants 18 years of age and older * Patients undergoing surgery for ocular disease * Adults able and willing to give informed consent to participate in the study Exclusion Criteria: * Patients with any ocular disease that restricts the ability to perform OCT scanning
Contact & Investigator
Cynthia A Toth, MD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT07024719 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Corneal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07024719 currently recruiting?
Yes, NCT07024719 is actively recruiting participants. Contact the research team at cynthia.toth@duke.edu for enrollment information.
Where is the NCT07024719 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT07024719 clinical trial?
NCT07024719 is sponsored by Duke University. The principal investigator is Cynthia A Toth, MD at Duke University. The trial plans to enroll 5 participants.